Named Executive Officer Compensation Information 2008 Bonus Awards
Contract Categories:
Human Resources
›
Bonus & Incentive Agreements
EX-10.25.1 2 f51118exv10w25w1.htm EX-10.25.1 exv10w25w1
Exhibit 10.25.1
Named Executive Officer Compensation Information — 2008 Bonus Awards
The table below provides information regarding the RSUs granted to the Company’s named executive officers in lieu of cash payments under the Bonus Plan for the 2008 performance period:
| Value of Cash | RSU Equivalent | |||||||
| Named Executive Officer | Bonus Award (1) | Grant (2) | ||||||
Ronald W. Barrett, PhD | $ | 266,250.00 | 9,872 | |||||
Chief Executive Officer | ||||||||
William G. Harris | $ | 82,687.50 | 3,065 | |||||
Senior Vice President of Finance and Chief Financial Officer | ||||||||
William J. Rieflin | $ | 150,820.31 | 5,592 | |||||
President | ||||||||
Kenneth C. Cundy, PhD | $ | 83,737.50 | 3,104 | |||||
Senior Vice President of Preclinical Development | ||||||||
David R. Savello, PhD | $ | 81,600.00 | 3,025 | |||||
Senior Vice President of Development | ||||||||
| (1) | Cash Bonus Award amounts determined under the Bonus Plan for the 2008 performance period. | |
| (2) | RSUs granted pursuant to the 2005 Equity Incentive Plan at the close of trading on January 14, 2009 at $26.97 per share (the closing stock price of the Company’s common stock on the Nasdaq Global Select Market), rounded down to the nearest whole share (no fractional shares were issued). The RSUs, which may be settled in stock, are immediately vested in full at the time of grant. |
